Skip to main content

Advertisement

ADVERTISEMENT

16th Biennial International Andreas Gruentzig Society Meeting

These proceedings summarize the educational activity of the 16th Biennial Meeting of the International Andreas Gruentzig Society held January 31-February 3, 2022 in Punta Cana, Dominican Republic

Faculty Disclosures     Vendor Acknowledgments

2022 IAGS Summary Document


Program Agenda

Session 1: Coronary Session 1—Elective PCI

1.1  PCI for QoL in Stable Ischemic Coronary Artery Disease

1.2 Plaque Modification: When to Apply Ablative vs Disruptive Therapies

1.3 Bifurcation Lesions: Stenting Strategies and Will DCBs Change Them?

Session 2: Structural Session 1—Aortic Valve

2.1 TAVR and PCI: Which Lesions and in Whom?

2.2 TAVR Durability: What is it Now and What Do We Need?

2.3 Stroke Prevention for TAVR: What’s Missing?

Session 3: Endovascular Session 1

3.1 Paclitaxel—Friend or Mortal Foe?

3.2 Aortic Frontiers: Will Branched Arch and Thoraco-abdominal Devices Outperform Surgery?

3.3 Carotid Artery Disease: CEA, CAS, TCAR, or Just Pills?

Session 4: Coronary Session 2—STEMI

4.1 COMPLETE Revascularization Following STEMI: Not Whether, When

4.2 Therapies to Minimize Myocardial Injury With and to Promote Myocardial Recovery Following STEMI

4.3 Interventional Pharmacology: Data-Driven Best Practices

Session 5: Structural Session 2—Mitral and Tricuspid Valve

5.1 Interventional vs Surgical Mitral Repair: Are Valve Centers of Excellence Needed?

5.2 TMVR: Programmatic Challenges and Technology Needed to Match Surgical Outcomes

5.3 Tricuspid Valve Interventions: Repair or Replace?

Session 6: Structural Session 3—Atrial

6.1 LAA Occlusion: Will the Latest Tools and Techniques Help Us Overcome the Barriers?

6.2 PFO Closure: What Goes Around Comes Around?

6.3 Multimodality Fusion Imaging for Structural Interventions

Session 7: Hemodynamics Session 1

7.1 Current Role of Hemodynamic Support in Complex, High-Risk PCI

7.2 Hemodynamic Support for STEMI: Door to Unloading Times and Do We Need Systems of Care?

7.3 Contemporary Management of Intermediate- and High-Risk Pulmonary Embolism

Session 8: Endovascular Session 2

8.1 Effectiveness Assessment in PAD: What are the Leading Treatments?

8.2 Drug Delivery for BTK Interventions: Which Drug and What Platform Will Get the Job Done?

8.3 Deep Venous Arterialization for Critical Limb Ischemia

Session 9: Emerging Therapies Session 1

9.1 Coronary Sinus Reduction for Refractory Ischemia

9.2 Current Status of Renal Denervation to Treat Hypertension

9.3 UHD and 3D Coronary Imaging

Session 10: Coronary Session 3

10.1 Latest Techniques and Devices for CTO Intervention: Will They Expand Indications?

10.2 Management of In-Stent Restenosis: Are DCBs the Answer?

10.3 Left Main Disease: How to Assess and When to Intervene in Patients With Aortic Valve Disease

Session 11: Health Care Delivery and Industry Session

11.1 Impact of COVID-19 on Cardiovascular Disease

11.2 Disaster Preparedness for the Cardiovascular Service Line

11.3 Censorship in Medicine: Politics in Science

Advertisement

Advertisement

Advertisement